a combined regimen consisting of double-dose third-generation EGFR-TKI, bevacizumab, and intrathecal chemotherapy in patients: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Leptomeningeal Metastasis | 1 |
| Lung Neoplasms, Non-Small Cell Lung Cancer | 1 |
| Lung cancer | 1 |
Recruiting trials involving a combined regimen consisting of double-dose third-generation EGFR-TKI, bevacizumab, and intrathecal chemotherapy in patients
Common questions
How many recruiting trials involve a combined regimen consisting of double-dose third-generation EGFR-TKI, bevacizumab, and intrathecal chemotherapy in patients?
1 recruiting trial across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.